WallStreetZenWallStreetZen

NASDAQ: HELP
Cybin Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HELP

Based on 3 analysts offering 12 month price targets for Cybin Inc

Min Forecast
$45.00+518.13%
Avg Forecast
$49.33+577.65%
Max Forecast
$55.00+655.49%

Should I buy or sell HELP stock?

Based on 3 analysts offering ratings for Cybin Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HELP's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HELP as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their HELP stock forecasts and price targets.

HELP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-03Find Out Why
lockedlocked$00.00+00.00%2025-11-20
lockedlocked$00.00+00.00%2025-11-14

1 of 1

Forecast return on equity

Is HELP forecast to generate an efficient return?

Company
-78.27%
Industry
255.08%
Market
228.47%
HELP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HELP forecast to generate an efficient return on assets?

Company
-60.02%
Industry
93.37%
HELP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HELP earnings per share forecast

What is HELP's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$4.49
Avg 2 year Forecast
-$2.81
Avg 3 year Forecast
-$3.37

HELP revenue forecast

What is HELP's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$26.1M

HELP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HELP$7.28$49.33+577.65%Strong Buy
TLSA$1.50N/AN/A
RANI$1.39$10.50+655.40%Strong Buy
IMMX$5.05$12.00+137.62%Buy
CRBU$1.77$8.50+380.23%Strong Buy
View Top Biotech Stocks

Cybin Stock Forecast FAQ

Is Cybin Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: HELP) stock is to Strong Buy HELP stock.

Out of 3 analysts, 2 (66.67%) are recommending HELP as a Strong Buy, 1 (33.33%) are recommending HELP as a Buy, 0 (0%) are recommending HELP as a Hold, 0 (0%) are recommending HELP as a Sell, and 0 (0%) are recommending HELP as a Strong Sell.

If you're new to stock investing, here's how to buy Cybin stock.

What is HELP's earnings growth forecast for 2026-2028?

(NASDAQ: HELP) Cybin's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 135.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 105.07%.

Cybin's earnings in 2026 is -$71,040,000.On average, 5 Wall Street analysts forecast HELP's earnings for 2026 to be -$103,430,257, with the lowest HELP earnings forecast at -$112,293,404, and the highest HELP earnings forecast at -$92,627,720. On average, 5 Wall Street analysts forecast HELP's earnings for 2027 to be -$64,764,546, with the lowest HELP earnings forecast at -$72,533,620, and the highest HELP earnings forecast at -$55,625,002.

In 2028, HELP is forecast to generate -$77,704,557 in earnings, with the lowest earnings forecast at -$100,221,742 and the highest earnings forecast at -$52,600,752.

What is HELP's revenue growth forecast for 2026-2028?

(NASDAQ: HELP) Cybin's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 312.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.74%.

Cybin's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast HELP's revenue for 2026 to be $0, with the lowest HELP revenue forecast at $0, and the highest HELP revenue forecast at $0. On average, 5 Wall Street analysts forecast HELP's revenue for 2027 to be $0, with the lowest HELP revenue forecast at $0, and the highest HELP revenue forecast at $0.

In 2028, HELP is forecast to generate $601,441,012 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $1,238,260,908.

What is HELP's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: HELP) forecast ROA is -60.02%, which is lower than the forecast US Biotechnology industry average of 93.37%.

What is HELP's Price Target?

According to 3 Wall Street analysts that have issued a 1 year HELP price target, the average HELP price target is $49.33, with the highest HELP stock price forecast at $55.00 and the lowest HELP stock price forecast at $45.00.

On average, Wall Street analysts predict that Cybin's share price could reach $49.33 by Dec 3, 2026. The average Cybin stock price prediction forecasts a potential upside of 577.65% from the current HELP share price of $7.28.

What is HELP's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: HELP) Cybin's current Earnings Per Share (EPS) is -$3.20. On average, analysts forecast that HELP's EPS will be -$4.49 for 2026, with the lowest EPS forecast at -$4.88, and the highest EPS forecast at -$4.02. On average, analysts forecast that HELP's EPS will be -$2.81 for 2027, with the lowest EPS forecast at -$3.15, and the highest EPS forecast at -$2.42. In 2028, HELP's EPS is forecast to hit -$3.37 (min: -$4.35, max: -$2.28).

What is HELP's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: HELP) forecast ROE is -78.27%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.